Our findings are important for understanding and treating AD as well as other neuropsychiatric and neurodegenerative disorders that are associated with reduced signaling through the ApoER2 pathway such as schizophrenia, autism, Down's syndrome, and bipolar disorder (Folsom & Fatemi, 2013). Here, LRP8 is linked to bipolar disorder.